We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+8.44%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$618M
AUM Growth
-$43.1M
Cap. Flow
-$63.8M
Cap. Flow %
-10.32%
Top 10 Hldgs %
7.4%
Holding
973
New
156
Increased
203
Reduced
222
Closed
372

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$3.94M
2
MRSH
Marsh
MRSH
+$3.18M
3
DXC icon
DXC Technology
DXC
+$3.13M
4
WAT icon
Waters Corp
WAT
+$3.01M
5
DPZ icon
Domino's
DPZ
+$2.73M

Top Sells

Rank Stock Value
1
HON icon
Honeywell
HON
+$3.17M
2
ATKR icon
Atkore
ATKR
+$3.17M
3
ANET icon
Arista Networks
ANET
+$3.02M
4
ENPH icon
Enphase Energy
ENPH
+$3M
5
EVH icon
Evolent Health
EVH
+$2.97M

Sector Composition

Rank Sector Weight
1 Technology 21.23%
2 Healthcare 18.83%
3 Financials 14.91%
4 Industrials 13.43%
5 Consumer Discretionary 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KOD icon
426
Kodiak Sciences
KOD
$2.5B
$410K 0.07%
57,298
-24,045
-30% -$173K
TBBK icon
427
The Bancorp
TBBK
$2.81B
$405K 0.07%
+14,268
New +$394K
MNTK icon
428
Montauk Renewables
MNTK
$253M
$403K 0.07%
36,576
+11,799
+48% +$158K
TVRD
429
Tvardi Therapeutics
TVRD
$20.1M
$401K 0.06%
1,037
+335
+48% +$127K
GPRK icon
430
GeoPark
GPRK
$609M
$399K 0.06%
25,796
HOV icon
431
Hovnanian Enterprises
HOV
$779M
$397K 0.06%
9,439
-34
-0.4% -$1.44K
PFBC icon
432
Preferred Bank
PFBC
$1.24B
$394K 0.06%
5,280
DBI icon
433
Designer Brands
DBI
$315M
$394K 0.06%
40,236
+24,705
+159% +$333K
LSCC icon
434
Lattice Semiconductor
LSCC
$16B
$389K 0.06%
6,000
AMSF icon
435
AMERISAFE
AMSF
$562M
$387K 0.06%
+7,437
New +$394K
SM icon
436
SM Energy
SM
$7.6B
$383K 0.06%
11,002
+28
+0.3% +$1.16K
NFE icon
437
New Fortress Energy
NFE
$92.9M
$382K 0.06%
9,005
-1,258
-12% -$60.8K
ONTF
438
DELISTED
ON24
ONTF
$381K 0.06%
+44,110
New +$354K
LZ icon
439
LegalZoom.com
LZ
$1.45B
$380K 0.06%
49,147
+17,391
+55% +$151K
EBC icon
440
Eastern Bankshares
EBC
$5.27B
$378K 0.06%
21,907
AFYA icon
441
Afya
AFYA
$1.35B
$377K 0.06%
+24,147
New +$359K
NWL icon
442
Newell Brands
NWL
$2.21B
$375K 0.06%
28,639
-31,160
-52% -$426K
SAGE
443
DELISTED
Sage Therapeutics
SAGE
$374K 0.06%
9,811
+152
+2% +$5.8K
STOK icon
444
Stoke Therapeutics
STOK
$1.84B
$373K 0.06%
40,462
+24,851
+159% +$258K
DCPH
445
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$369K 0.06%
22,510
-90,870
-80% -$1.48M
LBTYK icon
446
Liberty Global Class C
LBTYK
$3.5B
$367K 0.06%
+18,897
New +$357K
GSM icon
447
FerroAtlántica
GSM
$590M
$366K 0.06%
95,075
+84,517
+801% +$420K
PLMR icon
448
Palomar
PLMR
$3.79B
$364K 0.06%
8,068
-12
-0.1% -$818
TASK icon
449
TaskUs
TASK
$594M
$361K 0.06%
+21,382
New +$402K
HMN icon
450
Horace Mann Educators
HMN
$2.11B
$361K 0.06%
+9,668
New +$364K

Similar funds

PDT Partners's Q4 2022 Portfolio in Review

As of Q4 2022, PDT Partners held 973 positions worth $618M, down 6.5% from $661M the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

PDT Partners withdrew a net $63.8M in Q4 2022, closing 372 positions and reducing 222 holdings. Its most notable exit was Honeywell, an estimated $3.17M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, PDT Partners opened a new position in Guardant Health worth $2.34M.

  • PDT Partners's largest Q4 2022 buy was Guardant Health: 86,159 shares worth $2.34M.
  • PDT Partners added most to Waters Corp in Q4 2022, an estimated $3.01M increase.
  • PDT Partners's biggest Q4 2022 reduction was Enphase Energy, cutting an estimated $3M.
  • PDT Partners fully exited Honeywell in Q4 2022, selling an estimated $3.17M.
  • PDT Partners's ten largest holdings make up 7.4% of its $618M portfolio in Q4 2022.
  • PDT Partners opened 156 new positions and closed 372 in Q4 2022.
  • PDT Partners's portfolio value fell 6.5% quarter-over-quarter to $618M.

Based on PDT Partners's 13F filing for Q4 2022, filed 14 Feb 2023.